Psykologisk Institutt, Dragvoll
Trondheim, Norway
NCT Number: NCT02690584
The purpose of this open trial is to investigate the feasibility, acceptability, and effect of metacognitive therapy in patients with prolonged post-concussive symptoms after mild traumatic brain injury.
Looking for future studies?
Notify Me16 year–65 year
All sexes
Interventional
Not applicable
Trondheim, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Patients with prolonged recovery after mild TBI (GCS >12) will be recruited to our study if they have post concussive symptoms > 6 months after injury.
Patients will be recruited from an ongoing cohort study investigating mild and moderate TBI at St. Olavs Hospital and Trondheim Municipality Emergency Clinic, and in addition (as of October 2017) among TBI patients at St Olavs Hospital who were not included in the cohort study.
Inclusion criteria
Exclusion criteria
In addition to exclusion criteria already employed in the cohort study, patients with co-occurring psychiatric disorders that necessitate referral to specific treatment according to existing guidelines will be excluded from the current intervention study.
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after completed therapy
Time frame: 2 pre-treatment baseline measures, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: baseline, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: 3 pre-treatment baseline measures, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: 3 pre-treatment baseline measures, immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Time frame: 3 pre-treatment baseline measures, session to session (10 sessions), immediately after last therapy session, 10 weeks after completed therapy, 6 months after therapy
Norwegian University of Science and Technology
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02354469
Behavior, Brain Concussion
Boston, Massachusetts, United States
View Trial DetailsNCT06413173
Attention Concentration Difficulty, Attention Impaired
San Diego, California, United States
View Trial DetailsNCT01899924
Brain Diseases, Brain Injuries
Limoges, France
View Trial DetailsNCT05287542
Brain Diseases, Brain Injuries
Nesoddtangen, Akershus, Norway
View Trial Details